NME7 and breast carcinoma: NME7 might play tumor-suppressive role in breast cancer.[42] In HER2+breast cancer, AMPD1 might be a promising biomarker to predict disease outcomes.[43] Adedokun et al[44] also found that one of the breast cancer loci is near the AMPD2 gene.